Bar­gain sale con­tin­ues: As­traZeneca of­floads three res­pi­ra­to­ry drugs to Co­vis in $350M deal

In its sec­ond di­vesti­ture move with­in a week, As­traZeneca is bring­ing in $350 mil­lion by sell­ing three as­sets to Co­vis Phar­ma.

Zug, Switzer­land-based Co­vis first …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER